Physician profile
Joan Werleman
NPI 1417042920
$1,231.15
in general payments reported to CMS, 2019-2025
9 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $206 · 2021: $30.53 · 2022: $170 · 2023: $279 · 2024: $267 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516 · Gift: $113 · Consulting Fee: $75.00 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.10 |
| Gift | $112.99 |
| Consulting Fee | $75.00 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $588.44 | 2019-2025 | Invisalign, Itero Element 5d Plus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $263.35 | 2022-2025 | Xifaxan, Relistor, Plenvu |
| Ultradent Products INC | $123.99 | 2022-2023 | Opalescence |
| Dentsply Sirona INC | $111.03 | 2019-2025 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Septodont INC. | $72.93 | 2020 | |
| Zimvie INC. | $28.34 | 2025 | |
| Biohorizons Implant Systems INC. | $18.01 | 2020 | |
| Glaxosmithkline, LLC. | $13.18 | 2024 | Ojjaara |
| Orapharma, A Division of Bausch Health US, LLC | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Werleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.